Table 1.
Biomarker | Patient population (N) | Antibiotic administration (N) | p value | C index | Univariate OR [95% CI] | Multivariate OR [95% CI] |
---|---|---|---|---|---|---|
MR-proADM | 213 | 164 | < 0.001 | 0.76 | 3.1 [1.9–4.9] | 3.3 [1.9–5.9] |
PCT | 213 | 164 | < 0.001 | 0.74 | 2.7 [1.7–4.3] | 2.7 [1.7–4.5] |
CRP | 207 | 159 | < 0.001 | 0.68 | 1.8 [1.3–2.5] | 1.9 [1.4–2.8] |
Lactate | 204 | 158 | 0.002 | 0.66 | 1.8 [1.2–2.6] | 1.6 [1.1–2.5] |
Age, cardiovascular, neurological, renal and malignancy comorbidities were used as adjusting variables within the multivariate regression analysis, as previously outlined [4]. Univariate and multivariate odds ratios were expressed per 1 SD increment of the log-transformed value for each respective biomarker. CI confidence interval, CRP C-reactive protein, DF degrees of freedom, MR-proADM mid-regional proadrenomedullin, N number, OR odds ratio, PCT procalcitonin